Adenylate cyclase 5 and KCa1.1 channel are required for EGFR up-regulation of PCNA in native contractile rat basilar artery smooth muscle

J Physiol. 2006 Jan 1;570(Pt 1):73-84. doi: 10.1113/jphysiol.2005.100883. Epub 2005 Nov 10.

Abstract

In synthetic phenotype vascular smooth muscle cells (VSMC), activation of epidermal growth factor (EGF) receptor (EGFR) induces a sustained increase in intermediate conductance K(Ca) (int-K(Ca); K(Ca)3.1) channels that is essential for proliferation. However, a comparable mechanism has not been identified in native contractile phenotype VSMC, which express large conductance K(Ca) (maxi-K(Ca); K(Ca)1.1) channels, not int-K(Ca) channels. Using patch clamp of freshly isolated contractile VSMC from rat basilar artery, we found that EGF (100 ng ml(-1)) caused hyperpolarization (7.9 +/- 3.9 mV) due to activation of iberiotoxin-sensitive, maxi-K(Ca) channels. The EGFR ligands EGF (100 ng ml(-1)), transforming growth factor alpha (0.4 ng ml(-1)) and heparin-binding EGF (100 ng ml(-1)) all caused a 20% increase in maxi-K(Ca) channel current that was blocked by AG-1478 or by knock-down of EGFR expression using cisterna magna infusion of antisense oligodeoxynucleotide (AS-ODN). In controls, EGFR knock-down, and EGFR gain-of-expression (angiotensin II hypertension), the increase in maxi-K(Ca) current correlated with the abundance of EGFR protein expressed. The EGFR-mediated increase in maxi-K(Ca) channel activity was blocked by inhibiting cAMP-dependent protein kinase (cAK) using KT-5720 or Rp-cAMP, or by inhibiting adenylate cyclase type 5 (AC-5) using 2',5'-dideoxyadenosine or knock-down of AC-5 expression by intracisternal AS-ODN. Direct infusion of EGF into cisterna magna caused up-regulation of proliferating cell nuclear antigen (PCNA) in VSMC that was prevented by coinfusion of iberiotoxin or of AG-1478. Our data, which are consistent with the hypothesis that hyperpolarization is critical for a proliferative response, are the first to implicate AC-5 and maxi-K(Ca) channels in gene activation related to EGFR signalling in native contractile VSMC.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclase Inhibitors
  • Adenylyl Cyclases / genetics
  • Adenylyl Cyclases / metabolism*
  • Animals
  • Basilar Artery / enzymology
  • Cell Proliferation
  • Cyclic AMP-Dependent Protein Kinases / antagonists & inhibitors
  • Dideoxyadenosine / analogs & derivatives
  • Dideoxyadenosine / pharmacology
  • Epidermal Growth Factor / pharmacology
  • ErbB Receptors / drug effects
  • ErbB Receptors / genetics
  • ErbB Receptors / metabolism*
  • Female
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / genetics
  • Isoenzymes / metabolism*
  • Large-Conductance Calcium-Activated Potassium Channels / drug effects
  • Large-Conductance Calcium-Activated Potassium Channels / metabolism*
  • Membrane Potentials / drug effects
  • Muscle Contraction / drug effects
  • Muscle, Smooth, Vascular / drug effects
  • Muscle, Smooth, Vascular / enzymology*
  • Myocytes, Smooth Muscle / drug effects
  • Myocytes, Smooth Muscle / enzymology*
  • Oligonucleotides, Antisense / genetics
  • Oligonucleotides, Antisense / pharmacology
  • Patch-Clamp Techniques
  • Proliferating Cell Nuclear Antigen / metabolism*
  • Rats
  • Rats, Wistar
  • Signal Transduction / drug effects
  • Transforming Growth Factor alpha / pharmacology

Substances

  • Adenylyl Cyclase Inhibitors
  • Isoenzymes
  • Large-Conductance Calcium-Activated Potassium Channels
  • Oligonucleotides, Antisense
  • Proliferating Cell Nuclear Antigen
  • Transforming Growth Factor alpha
  • Dideoxyadenosine
  • Epidermal Growth Factor
  • 2',5'-dideoxyadenosine
  • ErbB Receptors
  • Cyclic AMP-Dependent Protein Kinases
  • Adenylyl Cyclases
  • adenylyl cyclase type V